Phillips, E <br/><br/>
Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States.  [electronic resource] 

 -  Clinical therapeutics   
 - 1070-84 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/s0149-2918(97)80060-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acne Vulgaris--chemically induced<br/>Adult<br/>Adverse Drug Reaction Reporting Systems<br/>Aged<br/>Alopecia--chemically induced<br/>Drug Combinations<br/>Estrogen Replacement Therapy--adverse effects<br/>Estrogens--adverse effects<br/>Estrogens, Esterified (USP)<br/>Female<br/>Hirsutism--chemically induced<br/>Humans<br/>Methyltestosterone--adverse effects<br/>Middle Aged<br/>Product Surveillance, Postmarketing<br/>United States